sellModerate
Shane Ward sold $2.2M of CDTX
COO & CLO at Cidara Therapeutics, Inc.. 9,959 shares at an average of $220.08, traded Dec 10, 2025, filed Dec 12, 2025.
Warning score
40Value
$2.2M
9,959 shares
Holdings after
25,033
-28% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- +25Trade size$2.2M at market
- +10Share of holdings soldSold 28% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001610618-25-000100, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2025 | FTax withholding Common Stock | -15,041 | $219.60 | $3.3M | 24,633 | Dec 12, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +3,500 | $16.65 | $58k | 28,133 | Dec 12, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +6,459 | $20.20 | $130k | 34,592 | Dec 12, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -9,959 | $220.08 | $2.2M | 25,033 | Dec 12, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -3,500 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -6,459 | $0.00 | $0 | 6,207 | Dec 12, 2025 |
Related signals
Other insiders at Cidara Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | CDTXbuy Cidara Therapeutics, Inc. | Jeffrey Stein President & CEO | $339k 4,262 shares | +7% | |
| 20Weak | CDTXsell Cidara Therapeutics, Inc. | Nicole Negar Davarpanah Chief Medical Officer | $30k 474 shares | -1% | |
| 50Moderate | CDTXbuy Cidara Therapeutics, Inc. | Ra Capital Management, L.p. director, owner | $100M 2,272,727 shares | +208% | |
| 31Weak | CDTXbuy Cidara Therapeutics, Inc. | Chrysa Mineo director | $74k 3,320 shares | - | |
| 29Weak | Cidara Therapeutics, Inc. | Leslie Tari CHIEF SCIENTIFIC OFFICER | $39k 1,773 shares | -10% | |
| 39Weak | Cidara Therapeutics, Inc. | Shane Ward COO & CLO | $37k 1,664 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.